/ Receives ANDA Approval For Amlodipine & Olmesartan Medoxomil Tablets ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Friday, 7 July 2017

Glenmark Pharmaceuticals Inc. USA (Glenmark) granted final approval by U.S FDA for the tablets of Amlodipine and Olmesartan Medoxomil, 5 mg/40 mg, 10 mg/20 mg, 5 mg/20 mg, 10 mg/40 mg, for Daiichi Sankyo, Inc 5 mg/20 mg, 5 mg/40 mg, 10 mg/ 40 mg, the generic version of Azor Tablets.

According to the IMS Health Sales the data for the 12 month period an ending period of May 2017, the market achieved the annual sales approx $211.6 million for the Azor Tablets 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, 10 mg/40 mg.

The current portfolio Glenmark consist of 119 products and it anauthorized distributor in U.S marketplace. And its pending approval with the U.S FDAUnited States Food & Drug Administration 66 ANDA, and it continues to explore development partnership for the supplement and the growth of its pipelines and its portfolio.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717